A carregar...
Inflammatory bowel disease surgery in the biologic era
Anti-tumour necrosis factor (TNF)-α therapy has revolutionized inflammatory bowel disease (IBD) treatment. Infliximab and adalimumab either as monotherapy or in combination with an immunomodulator are able to induce clinical and biological remission in patients with moderate and severe Crohn’s disea...
Na minha lista:
| Publicado no: | World J Gastrointest Surg |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4872064/ https://ncbi.nlm.nih.gov/pubmed/27231514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4240/wjgs.v8.i5.363 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|